Just as an FYI, I have been doing some digging into the Arthropharm oral OA trial (using Elmiron)...
They quote the following with regard to concerns anyone has with regard to Elmiron and retinal problems - “Very long-term continuous daily dosing (greater than 7 years, over 1.5 kg PPS accumulated dose) has been linked with a degenerative maculopathy in 20% of patients with interstitial cystitis, however the causative mechanism is yet to be established.”
PAR. SP, page-1133
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
-0.005(1.96%) |
Mkt cap ! $87.44M | |||
| Open | High | Low | Value | Volume |
| 25.5¢ | 25.5¢ | 24.0¢ | $45.48K | 182.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8935 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.5¢ | 29565 | 3 |
View Market Depth
| Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |